CD8A and neoplasm: Cancer vaccines function by activating and expanding tumor‐specific T cells (primarily CD8+ cytotoxic T lymphocytes [CTLs]), thereby enhancing tumor recognition and elimination while modulating the tumor immune microenvironment to restore immune surveillance capabilities [66, 67].